Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Initiates Coverage On Cepton with Neutral Rating

JP Morgan Initiates Coverage On Cepton with Neutral Rating

JP Morgan analyst Samik Chatterjee initiates coverage on Cepton (NASDAQ:CPTN) with a Neutral rating.

byBenzinga Newsdesk

September 20, 2022

1 minute read

JP Morgan analyst Samik Chatterjee initiates coverage on Cepton (NASDAQ:CPTN) with a Neutral rating.

T Stamp Q2 EPS $(0.13), Sales $710.00K

By Michael Horton

August 22, 4:46 PM

T Stamp (NASDAQ:IDAI) reported quarterly losses of $(0.13) per share. The company reported $710.00 thousand in sales this quarter.

IDAI

ImmunoGen Outperforms Q2 Revenue Expectations Bolstered By Strong Elahere Sales

By Vandana Singh

July 31, 10:09 AM

ImmunoGen Inc (NASDAQ: IMGN) reported Q2 revenues of $83.15 million, surpassing the consensus of $42.84 million and

IMGN

Crude Oil Rises 1%; Verastem Shares Slide

By Avi Kapoor

May 24, 2:47 PM

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on…

AKAN

HII Announces The Recent Sale Of Three REMUS 100s And Five REMUS 300s To The Royal Navy; No Financial Terms Disclosed

By Benzinga Newsdesk

May 6, 10:03 AM

HII, the leading manufacturer of underwater unmanned vehicles (UUVs), announced the recent sale of three REMUS 100s and five REMUS 300s to the Royal Navy. This transaction marks a significant milestone in the

HII

JP Morgan Initiates Coverage On Cepton with Neutral Rating

Related Posts

T Stamp Q2 EPS $(0.13), Sales $710.00K

ImmunoGen Outperforms Q2 Revenue Expectations Bolstered By Strong Elahere Sales

Crude Oil Rises 1%; Verastem Shares Slide

HII Announces The Recent Sale Of Three REMUS 100s And Five REMUS 300s To The Royal Navy; No Financial Terms Disclosed